{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:48:28Z","timestamp":1791186508643,"version":"4.1.0"},"reference-count":32,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[2010,9,1]]},"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A meta-analysis was performed using individual patient data from the five most recent randomised controlled trials (RCTs) which evaluated corticosteroids in severe alcoholic hepatitis (Maddrey discriminant function (DF) \u226532 or encephalopathy). This approach overcomes limitations associated with the use of literature data and improves the relevance of the study and estimates of effect size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To compare 28-day survival between corticosteroid- and non-corticosteroid-treated patients and to analyse the response to treatment using the Lille model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Individual patient data were obtained from five RCTs comparing corticosteroid treatment with placebo (n=3), enteral nutrition (n=1) or an antioxidant cocktail (n=1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>221 patients allocated to corticosteroid treatment and 197 allocated to non-corticosteroid treatment were analysed. The two groups were similar at baseline. 28-day survival was higher in corticosteroid-treated patients than in non-corticosteroid-treated patients (79.97\u00b12.8% vs 65.7\u00b13.4%, p=0.0005). In multivariate analysis, corticosteroids (p=0.005), DF (p=0.006), leucocytes (p=0.004), Lille score (p&lt;0.00001) and encephalopathy (p=0.003) were independently predictive of 28-day survival. A subgroup analysis was performed according to the percentile distribution of the Lille score. Patients were classified as complete responders (Lille score \u22640.16; \u226435th percentile), partial responders (Lille score 0.16\u20130.56; 35th\u201370th percentile) and null responders (Lille \u22650.56; \u226570th percentile). 28-day survival was strongly associated with these groupings (91.1\u00b12.7% vs 79.4\u00b13.8% vs 53.3\u00b15.1%, p&lt;0.0001). Corticosteroids had a significant effect on 28-day survival in complete responders (HR 0.18, p=0.006) and in partial responders (HR 0.38, p=0.04) but not in null responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Analysis of individual data from five RCTs showed that corticosteroids significantly improve 28-day survival in patients with severe alcoholic hepatitis. The survival benefit is mainly observed in patients classified as responders by the Lille model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gut.2010.224097","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T02:17:41Z","timestamp":1286936261000},"page":"255-260","source":"Crossref","is-referenced-by-count":368,"title":["Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data"],"prefix":"10.1136","volume":"60","author":[{"given":"Philippe","family":"Mathurin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Carithers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9","family":"Ramond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Naveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis C","family":"Maddrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"2025121223263189000_60.2.255.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0805786"},{"key":"2025121223263189000_60.2.255.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-3-311"},{"key":"2025121223263189000_60.2.255.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197106172842404"},{"key":"2025121223263189000_60.2.255.4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis","volume":"79","author":"Campra","year":"1973","journal-title":"Ann Intern Med"},{"key":"2025121223263189000_60.2.255.5","doi-asserted-by":"publisher","DOI":"10.1007\/BF01072499"},{"key":"2025121223263189000_60.2.255.6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"2025121223263189000_60.2.255.7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"2025121223263189000_60.2.255.8","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis","volume":"69","author":"Shumaker","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"2025121223263189000_60.2.255.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.1.75"},{"key":"2025121223263189000_60.2.255.10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"2025121223263189000_60.2.255.11","first-page":"769","article-title":"Traitement de l'h\u00e9patite alcoolique aigu\u00eb par la prednisolone","volume":"16","author":"Bories","year":"1987","journal-title":"Presse Med"},{"key":"2025121223263189000_60.2.255.12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"2025121223263189000_60.2.255.13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"2025121223263189000_60.2.255.14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"2025121223263189000_60.2.255.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00289-6"},{"key":"2025121223263189000_60.2.255.16","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.8627"},{"key":"2025121223263189000_60.2.255.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.11.039"},{"key":"2025121223263189000_60.2.255.18","first-page":"223","article-title":"Place de la corticoth\u00e9rapie dans le traitement des h\u00e9patites alcooliques aigu\u00ebs. R\u00e9sultats d'une m\u00e9ta-analyse","volume":"15","author":"Daures","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"2025121223263189000_60.2.255.19","first-page":"208","article-title":"Treatment of alcoholic hepatitis","volume":"2","author":"Reynolds","year":"1989","journal-title":"Gastroenterol Int"},{"key":"2025121223263189000_60.2.255.20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"2025121223263189000_60.2.255.21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.113"},{"key":"2025121223263189000_60.2.255.22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121223263189000_60.2.255.23","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93004-K"},{"key":"2025121223263189000_60.2.255.24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-136-12-200206180-00010","article-title":"Truth survival in clinical research: an evidence based requiem?","volume":"136","author":"Poynard","year":"2002","journal-title":"Ann Intern Med"},{"key":"2025121223263189000_60.2.255.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21607"},{"key":"2025121223263189000_60.2.255.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.062"},{"key":"2025121223263189000_60.2.255.27","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S"},{"key":"2025121223263189000_60.2.255.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.020"},{"key":"2025121223263189000_60.2.255.29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23043"},{"key":"2025121223263189000_60.2.255.30","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.09038"},{"key":"2025121223263189000_60.2.255.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.021"},{"key":"2025121223263189000_60.2.255.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23258"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.2010.224097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:26:40Z","timestamp":1765610800000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.2010.224097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,12]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,1,4]]},"published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1136\/gut.2010.224097"],"URL":"https:\/\/doi.org\/10.1136\/gut.2010.224097","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,12]]}}}